Reported Earlier, Lunai Bioworks Gets Nasdaq Delisting Determination Over $2.5M Equity Rule, Will Not Request Hearing, To Voluntarily Delist And Deregister
Share
Why It Matters
Lunai Bioworks did not meet Nasdaq's money rules. The company chose to leave Nasdaq instead of fighting.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.